AARTIPHARM

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Aarti Pharmalabs Limited

Aarti Pharmalabs Limited operates in the Healthcare sector, specializing in Drug Manufacturers - Specialty & Generic. The company manufactures and sells active pharmaceutical ingre...

हिन्दी में

आरती फार्मालैब्स लिमिटेड हेल्थकेयर क्षेत्र में कार्यरत है और ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक उप-क्षेत्र में विशेषज्ञता रखती है। यह कंपनी भारत और अंतरराष्ट्रीय स्तर पर ...

₹855.5-2.68%1D
Previous trading day close · Data updates after market close
1W: -9.6%
1M: +3.1%
6M: +23.7%
1Y: +3.1%
48/100
Below AvgResearch Score
Market Cap
₹6.3K Cr
Mid Cap
P/E Ratio
36.66
Fair
P/B Ratio
3.22
Premium
ROE
14.5%
Decent
ROCE
12.4%
Good
Debt / Equity
0.21
Low debt
Div. Yield
0.5%
EV/EBITDA
17.60
Fair
52W Low: ₹585Current: ₹855.552W High: ₹1,002.4
At 65% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
59/100
Growth
Revenue, EPS, profit growth
14/100
Valuation
PE, PB, EV/EBITDA vs sector
53/100
Risk
Debt levels, volatility, coverage
78/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
36.66(Fair)
Forward P/E
39.68(Premium)
P/B Ratio
3.22(Premium)
P/S Ratio
3.49(Good)
EV/EBITDA
17.60(Expensive)
Dividend Yield
0.5%
5Y CAGR
N/A
Revenue Growth
-13.6%(Moderate)
Profitability
ROE
14.5%(Average)
ROCE
12.4%(Good)
ROA
9.9%(Average)
Net Margin
9.5%(Decent)
EBITDA Margin
20.9%
Financial Health
Debt to Equity
0.21(Low debt)
Current Ratio
2.01(Healthy)
Quick Ratio
1.12(Good)
Interest Coverage
5.97x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
54(Neutral)
RSI Exp (14)
35(Neutral)
MACD
23.585(Bullish)
MACD Signal
31.273
BB Position
35%(Middle)
BB Width
28.14%(High volatility)
ADX (14)
28.7(Strong trend)
Williams %R
-76.8(Neutral)
MFI (14)
77(Neutral)
CCI (20)
-35(Neutral)
Stoch %K
23(Neutral)
ATR (14)
54.86(Avg True Range)
OBV (M)
51.3(Positive)
1W OBV Chg
-4.1%(Decreasing)
Rel Volume
0.54x(Normal)
Volatility
46.0%(High)
Max DD 1Y
-38.6%(Moderate)
EMA 200
770.1
EMA 50
849.5
SMA 200
739.5
vs SMA 50
1.4%(Above SMA50)
vs SMA 200
15.7%(Above SMA200)
Volume
4.44L
Avg Vol 3M
8.2L
Shareholding Pattern
Promoter
43.1%
Moderate
FII
8.4%
DII / MF
7.4%
Share AARTIPHARM
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.